RCMI Coordinating Center (RCMI CC) Header Logo

Connection

J Goodwin to Antineoplastic Agents, Hormonal

Back to Details
This is a "connection" page, showing publications J Goodwin has written about Antineoplastic Agents, Hormonal.
J Goodwin
Connection Strength
0.465
Antineoplastic Agents, Hormonal
  1. Shahinian VB, Kuo YF, Freeman JL, Goodwin JS. Determinants of androgen deprivation therapy use for prostate cancer: role of the urologist. J Natl Cancer Inst. 2006 Jun 21; 98(12):839-45.
    View in: PubMed
    Score: 0.242
  2. Shahinian VB, Kuo YF, Freeman JL, Orihuela E, Goodwin JS. Increasing use of gonadotropin-releasing hormone agonists for the treatment of localized prostate carcinoma. Cancer. 2005 Apr 15; 103(8):1615-24.
    View in: PubMed
    Score: 0.223
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support